Company news

MindWalk Holdings Corp. news in 2026

MindWalk Holdings Corp.'s news releases, calls and decks from 2026, newest first.

View company

MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows

November 4, 2026

MindWalk Holdings Corp. Announces Leadership Update

October 22, 2026

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours

October 21, 2026

MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

October 14, 2026

MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function

October 6, 2026

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

October 1, 2026

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

September 21, 2026

MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027

September 14, 2026

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

September 14, 2026

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

September 8, 2026

MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

July 22, 2026

MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure

July 22, 2026

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026

July 13, 2026

MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity

July 6, 2026

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

July 1, 2026

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

June 12, 2026

MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ, a Biological Context Layer for AI Drug Discovery

June 11, 2026

MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery

June 10, 2026

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns

June 2, 2026

MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage

May 26, 2026

The Biology Came First.

May 18, 2026

Third Quarter 2026 Transcript

March 16, 2026

MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results

March 11, 2026

MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era

March 5, 2026

MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026

March 2, 2026

MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics

January 27, 2026

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease

January 13, 2026

REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight

January 12, 2026

MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight

January 8, 2026

Calls in 2026

Decks in 2026